FCM
CRL icon

Frontier Capital Management’s Charles River Laboratories CRL Stock Holding History

Frontier Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.29M Sell
48,062
-75,639
-61% -$14M 0.09% 250
2025
Q4 		$24.7M Buy
123,701
+73,426
+146% +$13.3M 0.26% 144
2025
Q3 		$7.87M Sell
50,275
-1,526
-3% -$242K 0.07% 262
2025
Q2 		$7.86M Sell
51,801
-19,271
-27% -$2.57M 0.07% 259
2025
Q1 		$10.7M Sell
71,072
-2,143
-3% -$359K 0.12% 211
2024
Q4 		$13.5M Sell
73,215
-133
-0.2% -$25.6K 0.13% 195
2024
Q3 		$14.4M Sell
73,348
-1,033
-1% -$215K 0.14% 193
2024
Q2 		$15.4M Buy
74,381
+6,255
+9% +$1.42M 0.15% 192
2024
Q1 		$18.5M Buy
68,126
+17,003
+33% +$4.06M 0.17% 170
2023
Q4 		$12.1M Buy
51,123
+3,711
+8% +$730K 0.12% 190
2023
Q3 		$9.29M Buy
47,412
+20,076
+73% +$4.12M 0.1% 197
2023
Q2 		$5.75M Sell
27,336
-279
-1% -$55.5K 0.06% 227
2023
Q1 		$5.57M Sell
27,615
-2,492
-8% -$565K 0.06% 224
2022
Q4 		$6.56M Buy
+30,107
New +$6.57M 0.07% 220
2014
Q2 		– Sell
-317
Closed -$19K – 346
2014
Q1 		$19K Sell
317
-891,784
-100% -$52M ﹤0.01% 337
2013
Q4 		$47.3M Buy
892,101
+43,521
+5% +$2.19M 0.35% 101
2013
Q3 		$39.3M Buy
848,580
+118,850
+16% +$5.45M 0.3% 114
2013
Q2 		$29.9M Buy
+729,730
New +$31.3M 0.25% 146

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Frontier Capital Management's CRL Position: Q1 2026 in Review

Frontier Capital Management reduced its Charles River Laboratories (CRL) stake by 61% in Q1 2026, selling an estimated $14M and leaving 48,062 shares worth $8.29M. The position accounts for 0.09% of the portfolio, ranked #250.

Frontier Capital Management first reported a position in CRL in Q2 2013 and has held it in 18 quarters since. The position peaked at $47.3M in Q4 2013. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Frontier Capital Management held 48,062 shares of Charles River Laboratories worth $8.29M as of Q1 2026.
  • Frontier Capital Management sold 75,639 Charles River Laboratories shares in Q1 2026, an estimated $14M.
  • Charles River Laboratories made up 0.09% of Frontier Capital Management's portfolio in Q1 2026, its #250 holding.
  • Frontier Capital Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 18 quarters since.
  • Frontier Capital Management's Charles River Laboratories position peaked at $47.3M in Q4 2013.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Frontier Capital Management's 13F filing for Q1 2026, filed 15 May 2026.